Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Delee
AddedFeb 16, 2024
UpdatedJun 18, 2026
Delee

Delee

Delee: Early cancer diagnosis & treatment monitoring via blood tests.

HQ
San Francisco, CA, US
Founded
2017
Accelerator
Y Combinator logoY CombinatorW17
Overview
Compare
Fundraising
Employees
Website

Delee is a medical device company focused on revolutionizing early cancer diagnosis and treatment monitoring through advanced blood-testing technology. Their flagship product, CytoCatchâ„¢, is designed to isolate and analyze circulating tumor cells (CTCs) with high efficiency and reproducibility. This fully automated system aims to provide accurate and timely information for better clinical decision-making, targeting the oncology market.

Delee has made significant strides in the field of cancer diagnostics, leveraging cutting-edge technology to address critical challenges in early detection and treatment monitoring. Their innovative approach has garnered attention for its potential to improve patient outcomes and streamline cancer care. The company's impact is underscored by its commitment to high-performance solutions that meet stringent medical standards.

Delee - Similar Companies

AxonDx logo

AxonDx

axondx.com

Droplet Biosciences logo

Droplet Biosciences

dropletbiosci.com

OnCirc Diagnostics logo

OnCirc Diagnostics

Adela logo

Adela

adelabio.com

Delfi Diagnostics logo

Delfi Diagnostics

Leuko logo

Leuko

leuko.io

LeukoDx logo

LeukoDx

Cyto Wave Technologies logo

Cyto Wave Technologies

BloodQ logo

BloodQ

bloodq.com

X-Zell logo

X-Zell

x-zell.com

CytoLogic logo

CytoLogic

DotLab logo

DotLab

dotlab.com

OncoHealth logo

OncoHealth

oncohealthcorp.com

Cellens logo

Cellens

cellensinc.com

Cleveland Diagnostics logo

Cleveland Diagnostics

clevelanddx.com

Delee - Quick Facts

Who are Delee's competitors?

Companies similar to Delee include AxonDx, Droplet Biosciences, OnCirc Diagnostics and Adela.

When was Delee founded?

Delee was founded in 2017.

Where is Delee's headquarters located?

Delee's headquarters is located in San Francisco, CA, US.

How much has Delee raised to-date?

As of Oct 1, 2022, Delee has raised a total of $2.4M (USD).

How many employees does Delee have?

Delee has 20 employees as of Feb 5, 2024.

Delee - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 21 more industry codes
NAICS
  • 513200Software Publishers
  • 540000Professional, Scientific, and Technical Services
  • 330000Manufacturing
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541900Other Professional, Scientific, and Technical Services
  • 513210Software Publishers
  • 541990All Other Professional, Scientific, and Technical Services
SIC
  • 8900Services, Not Elsewhere Classified
  • 8990Services, Not Elsewhere Classified
  • 8999Services, Not Elsewhere Classified
  • 3900Miscellaneous Manufacturing Industries
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified